AI

  • NHS launches ‘trailblazing’ AI and robotics lung cancer trial

    The NHS is piloting AI and robotics to diagnose hard-to-reach lung cancer sooner, aiming to reduce repeat scans and invasive tests. The approach uses AI software to analyse lung scans and flag small lumps most likely to be cancer. A robotic camera then guides biopsy tools through the airways, reaching nodules as small as 6mm, [...]

  • FDA-cleared AI detects heart disease from a single view

    AI Point-of-Care Diagnostics company AISAP has announced the publication of a new clinical study in the peer-reviewed journal Frontiers in Digital Health. The research provides clinical evidence that AISAP’s deep learning model can accurately detect significant valvular disease and ventricular dysfunction using only a single, focused ultrasound view, even when the images are acquired by [...]

  • Why Britain’s health tech AI rules may leave it watching from the sidelines

    Orlando Agrippa comments on why tightening regulation must not come at the expense of progress for patients In recent years, a quiet but consequential transformation has been unfolding far above the Earth’s surface. Thousands of satellites have been placed into low-Earth orbit, forming a dense and expanding digital mesh around the planet. With further large-scale [...]

  • CluePoints appoints chief people officer to drive global growth

    CluePoints, provider of leading statistical and AI-driven software solutions, has appointed Sinead Godkin as its new chief people officer (CPO). With deep experience scaling global technology organisations through periods of rapid growth, Godkin will lead CluePoints’ people strategy as the company enters its next stage of expansion. Godkin brings senior leadership experience from some of [...]

  • StuffThatWorks appoints Julie A. Ross as CEO and president

    StuffThatWorks has announced that Julie A. Ross, former CEO of global CRO Advanced Clinical, has joined the company as Chief Executive Officer and president, effective immediately. Ross will lead the company’s next phase of growth as it scales its proprietary patient-derived AI model designed to address the most persistent constraint in pharmaceutical development: lack of [...]

  • PharmaForceIQ acquires Aktana to boost cross-functional engagement in pharma

    PharmaForceIQ has announced its acquisition of Aktana, aligning its cutting-edge digital orchestration platform with the industry’s premier AI-driven field Next-Best-Action (NBA) platform. The strategic move creates the industry’s first optichannel-in-a-box solution for pharma companies – an end-to-end commercial customer engagement system that can go live in as little as 6–8 weeks. This becomes the most [...]

  • Eolas Medical raises US$12m

    Eolas Medical has raised US$12m in series A funding to scale its AI search tools within the NHS. Its platform is already used at more than 400 clinical sites in the UK, according to the company. The Northern Irish health-tech start-up said its AI search platform aims to provide “point-of-care knowledge tools supporting clinical safety, [...]

  • X-on Health and TORTUS AI confirmed for NHS England ambient voice tech registry

    Primary care digital front door supplier X-on Health, in partnership with delivery partner TORTUS, has been confirmed as one of the first self-certified suppliers on the newly launched NHS England Ambient Voice Technology (AVT) Registry. The confirmation recognises the use of X-on Health’s Surgery Intellect incorporating ambient voice capability using TORTUS technology, supporting GP practices [...]

  • OpenEvidence doubles valuation to US$12bn after funding

    AI startup OpenEvidence has doubled its valuation to US$12bn after raising US$250m in a new funding round. OpenEvidence develops artificial intelligence tools designed to help doctors search and interpret medical information more quickly. The Miami-based company trains its chatbot on specialised medical content from scientific publications and clinical sources to support physicians during decision-making. The [...]

  • Securing the future of digital pathology

    By David Gibbs, pathology network director at Peninsula Pathology Network The ongoing transformation of the pathology sector is driven by rising demand for faster and more accurate diagnosis, workforce pressures and policy reform. It is continually being reshaped by rapid advancements in technology and the introduction of artificial intelligence (AI) promises next level accuracy and [...]